| Cancer-related molecular mechanisms research | Lifetime | 176 | CN 73 | 99.24 |
| Microplastics and Plastic Pollution | Lifetime | 87 | CN 27 | 99.20 |
| MicroRNA in disease regulation | Lifetime | 304 | CN 106 | 98.87 |
| RNA modifications and cancer | Lifetime | 760 | CN 94 | 98.56 |
| Aquaculture disease management and microbiota | Lifetime | 290 | CN 49 | 98.50 |
| Pharmaceutical and Antibiotic Environmental Impacts | Lifetime | 447 | CN 122 | 98.05 |
| Circular RNAs in diseases | Lifetime | 516 | CN 272 | 96.98 |
| interferon and immune responses | Lifetime | 495 | CN 42 | 96.85 |
| Animal Virus Infections Studies | Lifetime | 766 | CN 65 | 96.89 |
| Cancer-related gene regulation | Lifetime | 859 | CN 115 | 96.21 |
| Recycling and Waste Management Techniques | Lifetime | 582 | CN 140 | 96.44 |
| Signaling Pathways in Disease | Lifetime | 460 | CN 18 | 95.50 |
| Endoplasmic Reticulum Stress and Disease | Lifetime | 814 | CN 32 | 95.31 |
| Ferroptosis and cancer prognosis | Lifetime | 853 | CN 504 | 93.03 |
| Biomarkers in Disease Mechanisms | Lifetime | 767 | CN 67 | 81.81 |
| Belt Conveyor Systems Engineering | Lifetime | 806 | CN 174 | 68.16 |
| interferon and immune responses | 2021-2025 | 8 | CN 3 | 98.77 |
| Microplastics and Plastic Pollution | 2021-2025 | 20 | CN 8 | 99.46 |
| Cancer-related molecular mechanisms research | 2021-2025 | 44 | CN 29 | 99.57 |
| MicroRNA in disease regulation | 2021-2025 | 36 | CN 19 | 99.40 |
| Aquaculture disease management and microbiota | 2021-2025 | 22 | CN 7 | 99.40 |
| RNA modifications and cancer | 2021-2025 | 213 | CN 142 | 97.93 |
| Immune cells in cancer | 2021-2025 | 119 | CN 72 | 97.18 |
| biodegradable polymer synthesis and properties | 2021-2025 | 155 | CN 66 | 97.09 |
| Neuroinflammation and Neurodegeneration Mechanisms | 2021-2025 | 166 | CN 54 | 96.63 |
| Antimicrobial Peptides and Activities | 2021-2025 | 70 | CN 33 | 95.41 |
| Marine Biology and Environmental Chemistry | 2021-2025 | 44 | CN 31 | 94.98 |
| Pharmaceutical and Antibiotic Environmental Impacts | 2021-2025 | 245 | CN 157 | 96.13 |
| Radiomics and Machine Learning in Medical Imaging | 2021-2025 | 828 | CN 247 | 95.12 |
| Cancer, Hypoxia, and Metabolism | 2021-2025 | 353 | CN 150 | 92.39 |
| Circular RNAs in diseases | 2021-2025 | 257 | CN 187 | 94.49 |
| Recycling and Waste Management Techniques | 2021-2025 | 372 | CN 141 | 94.92 |
| Animal Virus Infections Studies | 2021-2025 | 304 | CN 127 | 92.73 |
| Effects and risks of endocrine disrupting chemicals | 2021-2025 | 210 | CN 80 | 93.26 |
| Ferroptosis and cancer prognosis | 2021-2025 | 530 | CN 445 | 93.33 |
| Neurological Disease Mechanisms and Treatments | 2021-2025 | 134 | CN 55 | 91.59 |
| Cancer, Lipids, and Metabolism | 2021-2025 | 354 | CN 122 | 91.38 |
| Antibiotic Resistance in Bacteria | 2021-2025 | 633 | CN 167 | 93.69 |
| Biomarkers in Disease Mechanisms | 2021-2025 | 36 | CN 12 | 86.34 |
| Vaccine Coverage and Hesitancy | 2021-2025 | 633 | CN 53 | 92.77 |
| Spinal Fractures and Fixation Techniques | 2021-2025 | 476 | CN 51 | 93.15 |
| Virology and Viral Diseases | 2021-2025 | 156 | CN 23 | 88.05 |
| Cancer-related gene regulation | 2021-2025 | 375 | CN 252 | 87.20 |
| Infectious Diseases and Tuberculosis | 2021-2025 | 221 | CN 19 | 87.87 |
| Inflammasome and immune disorders | 2021-2025 | 533 | CN 257 | 87.29 |
| Bone Metabolism and Diseases | 2021-2025 | 326 | CN 144 | 84.18 |
| Streptococcal Infections and Treatments | 2021-2025 | 620 | CN 72 | 80.38 |
| Postharvest Quality and Shelf Life Management | 2021-2025 | 967 | CN 477 | 81.32 |
| Cancer Mechanisms and Therapy | 2021-2025 | 776 | CN 345 | 74.44 |
| Inflammatory Biomarkers in Disease Prognosis | 2021-2025 | 933 | CN 385 | 72.89 |
| Bacterial Infections and Vaccines | 2021-2025 | 735 | CN 71 | 73.87 |
| Pediatric health and respiratory diseases | 2021-2025 | 789 | CN 84 | 73.75 |
| Vibrio bacteria research studies | 2021-2025 | 997 | CN 305 | 73.67 |
| Toxoplasma gondii Research Studies | 2021-2025 | 526 | CN 111 | 74.21 |
| Hedgehog Signaling Pathway Studies | 2021-2025 | 381 | CN 66 | 65.61 |
| Animal Genetics and Reproduction | 2021-2025 | 709 | CN 266 | 68.12 |
| Ginseng Biological Effects and Applications | 2021-2025 | 871 | CN 705 | 67.51 |
| Reproductive biology and impacts on aquatic species | 2021-2025 | 932 | CN 312 | 66.88 |
| Neuroprotection in Stroke and Neurodegeneration | 2021-2025 | 898 | CN 132 | 65.50 |
| Sirtuins and Resveratrol in Medicine | 2021-2025 | 881 | CN 315 | 55.83 |
| Polyamine Metabolism and Applications | 2021-2025 | 893 | CN 362 | 48.93 |
| Medicinal Plant Pharmacodynamics Research | 2021-2025 | 195 | CN 172 | 49.63 |
| Methemoglobinemia and Tumor Lysis Syndrome | 2021-2025 | 190 | CN 21 | 36.48 |
| Flavonoids in Medical Research | 2021-2025 | 615 | CN 284 | 35.77 |
| NF-κB Signaling Pathways | 2021-2025 | 833 | CN 338 | 32.81 |
